More than 1200 Queenslanders are participating in the state’s PrEP trial as part of efforts to prevent the transmission of HIV, the Queensland government has announced.
PrEP, short for Pre-Exposure Prophylaxis and also known by its brand name Truvada, is a once-daily pill that has been shown to dramatically reduce the risk of HIV transmission in people at high risk.
Queensland’s QPrEP trial project – a collaboration between the Queensland AIDS Council, the University of Queensland, the Cairns Sexual Health Service and Queensland Health – was expanded to 2000 places last year and appointments with participants commenced last November.
Health Minister Cameron Dick said there are still about 800 places available on the trial and he encouraged more eligible Queenslanders to get involved.
“The research shows PrEP can dramatically reduce the risk of contracting HIV, so this trial really has the potential to positively impact the lives of Queenslanders at high risk of contracting the virus,” he said.
“As part of our Sexual Health Strategy, the first of its kind in Australia, we are actively looking to increase the uptake of HIV prevention strategies and the PrEP trial is a key part of this.”
Twenty QPrEP trial sites in Brisbane, Ipswich, Toowoomba, Gold Coast, Sunshine Coast, Bundaberg, Rockhampton, Mackay, Townsville and Cairns are now operational, including sexual health services, GPs, and community-based organisations across the state.
Queenslanders are eligible to participate in the trial if they are HIV negative and are at high risk of acquiring HIV, which includes gay or bisexual men. The PrEP medication is provided free to trial participants.
For more information and to get involved, visit the QPrEP website.